Evidence map›Paper›PMID 42540089›Full record

ArticleEULAR rheumatology open2026

Corrigendum to <EGPAware: a European Delphi consensus study on red flags for suspicion of eosinophilic granulomatosis with polyangiitis> <EULAR Rheumatology Open Vol. 2 Issue 1 (2026) 9-18 /ERO-D-25-00108>.

Bernhard Hellmich, Benjamin Terrier, Apostolos Bossios, Christian Domingo, Cristina Ponte, Roser Solans-Laque, Íñigo Rúa-Figueroa, Dimitrios Vassilopoulos, Gabriele Brembilla, Konstantina Kallinikou and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Bernhard HellmichMedius Klinik Kirchheim, Kirchheim unter Teck, Germany.
Benjamin TerrierCochin Hospital, Paris, France.
Apostolos BossiosKarolinska Severe Asthma Centre, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden.
Christian DomingoParc Taulí University Hospital, Parc Taulí Institute of Investigation and Innovation (I3PT-CERCA), Medicine Department, Universitat Autònoma de Barcelona (UAB), Sabadell, Barcelona, Spain.
Cristina PonteULS de Santa Maria, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Roser Solans-LaqueVall d'Hebron University Hospital, Barcelona, Spain.
Íñigo Rúa-FigueroaGran Canaria Doctor Negrín Hospital, Las Palmas de Gran Canaria, Spain.
Dimitrios VassilopoulosNational and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Gabriele BrembillaGlaxoSmithKline, Medical Department, Verona, Italy.
Konstantina KallinikouGlaxoSmithKline, Respiratory Biologics, Athens, Greece.
Giacomo EmmiDepartment of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Augusto VaglioDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.ero.2025.11.014.].

Identifiers

PMID42540089
PMCPMC13425224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.